Carisoprodol
Product Images NDC 67046-911

2 FDA label images from Contract Pharmacy Services-pa · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Carisoprodol (NDC 67046-911). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Contract Pharmacy Services-pa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

This In An Image Of The Structural Formula Of Carisoprodol. (Carisoprodol 1)

This In An Image Of The Structural Formula Of Carisoprodol. (Carisoprodol 1)
Chemical structure diagram of Carisoprodol, illustrating its molecular formula with labeled carbon, hydrogen, nitrogen, and oxygen atoms arranged in its characteristic structural configuration.*
FDA Label Image

Image Of The Carisoprodol Tablets, Usp 350 mg 100 Tablets Label (Carisoprodol 2)

Image Of The Carisoprodol Tablets, Usp 350 mg 100 Tablets Label (Carisoprodol 2)
Label for Carisoprodol 350 mg tablets, packaged by Contract Pharmacy Services-PA. The label indicates a bottle containing 30 tablets with the notation "Rx Only" and controlled substance status as Schedule IV. Expiration date and lot number are shown, along with usual adult dosage instructions and storage conditions. The NDC number 67046-911-30 is visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.